Intuitive Surgical has been discreetly advancing its strategy within the realm of gastrointestinal flexible endoscopic robots. Its digestive endoscopy robot, the IG1000, secured FDA approval for market release on August 7 and has also filed a 510(k) registration application for a non-commercial variant. This product, equipped with a force feedback system and leveraging shape-sensing and locking technology, is designed to tackle clinical challenges in endoscopic therapy and reduce the complexity of endoscopic surgical procedures. Presently, this field has drawn strategic interest from numerous companies. Olympus has embraced a dual approach of external collaboration and internal R&D, with EndoQuest making significant strides. In China, Robo Medical’s related products have already obtained sales approval, and Aohua Medical’s ERCP surgical robot has successfully navigated the special review process for innovative medical devices, initiating multi-center clinical trials. The entrance of Intuitive Surgical is anticipated to capitalize on its strengths in commercialization and market expansion, propelling the field from technological validation to widespread clinical application.